Silvec Biologics
BioTech/Drugs - Rockville, MD, US
Silvec Biologics Employees
Silvec Biologics Senior Management
Silvec Biologics Details
Similar to BioNTech and Moderna, which develop RNA-based therapies for humans, Silvec provides best-in-class RNA-based solutions for long-lived plants including vaccinating against most diseases, enhancing their ability to grow in marginal soils, and improving their product quality.Potential demand is incredibly high as global travel, international trade and climate change fuel an exponential spread of invasive pathogens that are killing or depleting trees, bushes and vines in all sectors of agriculture, timber and forestry.Silvec's solution works at all stages of a plant's life—it can be administered to seedlings and mature trees alike, and with just a single application it provides a lifetime of protection without altering the plant's genome.Silvec's product can also provide a platform for a complete suite of trait-enhancements that can help plants tolerate multiple conditions related to climate change. The platform can deliver enhancements including enhanced carbon capture, drought and flood tolerance, increased growth rates, reduced chemical inputs, delayed post-harvest rot, and enhanced disease resistance callose downregulation.Silvec Biologics was co-founded by Chief Technology Officer Dr. Anne Elizabeth Simon, a leading plant pathogen expert and geneticist out of the University of Maryland, and President Dr. Rafael Simon co-founder of several cleantech and biotech companies. The company has an all-star executive team including Julie Friedman Steele, Executive Chair of the Board / Chief Strategy Officer and research team.
Silvec Biologics Technologies
Email Providers
Gmail
Load Balancers
Varnish
Hosting
Google Cloud Hosting
Other
Mobile Friendly